--- title: The only LIMS platform fully developed on FAIR data principles launches at Bio-IT World 2023 description: The Labbit LIMS platform delivers fully FAIR-compliant, truly interoperable data from day one, driving operational efficiencies, improved cross-collaboration and quicker, better-informed decision-making. image: https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (34)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (20)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (15)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (244)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (9)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (108)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (283)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (35)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Drug Discovery & Development (147)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (55)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (132)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (6)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (25)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (86)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (114)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (4)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (5)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates - ##### SHARE - - - # [The only LIMS platform fully developed on FAIR data principles launches at Bio-IT World 2023](https://news.lifesciencenewswire.com/newsroom/the-only-lims-platform-fully-developed-on-fair-data-principles-launches-at-bio-it-world-2023) May 25, 2023 *The Labbit LIMS platform delivers FAIR-compliant, truly interoperable data from day one, driving operational efficiencies, improved cross-collaboration, and quicker, better-informed decision making* In response to the data management needs of laboratories worldwide, Labbit emerges as a game-changer in the industry. Unlike any other LIMS platforms available, Labbit has been built as FAIR from the ground up and so data is findable, accessible, interoperable, and reusable from day one.  As a cloud-based platform, it offers unlimited flexibility, allowing laboratories to streamline their operations by tailoring the platform to align with their unique processes and workflows. What’s more, the platform enables any number of integrations (including with artificial intelligence and machine learning software) and limitless scaling, providing a future-proof system that can evolve as fast as an organization’s needs. Today, most LIMS are inflexible, use non-standard data formats, and are built on old databases that restrict access to data when you need it, in the format scientists, data scientists, and business leaders need it in. These conventional systems rely on locked down data models, which prevent laboratories from easily capturing emergent data and metadata, making it difficult and time consuming to complete audits while also preventing real-time problem solving. To meet the challenges faced by laboratories, Labbit takes a progressive approach, by collecting data using international standards, including W3-PROV, and storing it in a knowledge graph RDF database. This cutting-edge methodology ensures that all contextual information is encoded in machine-readable metadata, which empowers users with unparalleled data accessibility and sharing capabilities. With Labbit, laboratories can effortlessly incorporate additional fields, conduct ad-hoc queries, and capture data with the utmost precision. Due to the platform’s boundless flexibility and limitless scalability, Labbit is the ideal solution for high-growth and complex laboratories, which are often hindered by having to manage several cumbersome informatics systems that do not ideally meet their needs. “After investing more than 300,000 hours designing and implementing software solutions for labs that push the boundaries of throughput, complexity, and innovation, we learned that the ideal informatics solution is easy-to-maintain with flexible integrations, powerful visual workflow creation tools, easily accessible data, and metadata, and is fully scalable.” explained Dave Bell, Head of Product Engineering. “That’s why we developed Labbit, a FAIR-data LIMS that supports, manages, controls, and visualizes the entire laboratory workflow lifecycle, from ideation to verification and validation, and operational scaling.” “We’re now delighted to invite customers to use Labbit and discover how this powerful tool can transform their workflows and truly bring efficiencies to their laboratories,” continued Peter Smith, CEO. “In 2023, we will partner with a select number of customers, and invite labs who are looking to work with a deeply experienced provider to configure a genuinely flexible, interoperable laboratory informatics platform that enables them to grow *and* be FAIR compliant, to get in touch.” To speak to a consultant about becoming one of the first labs to experience Labbit, the new generation of LIMS, visit [Labbit.com](http://Labbit.com) About Labbit Labbit is the brainchild of the Canadian software company [Semaphore Solutions](https://semaphoresolutions.com/).  Semaphore is a team of 65 informatics experts with a long history of supporting laboratories with LIMS implementation, customization, and custom software. Under development since 2019 the Labbit LIMS platform is built on FAIR data principles and leverages advanced technologies such as knowledge graph databases and BPMN. Labbit offers laboratories unparalleled flexibility, data accessibility, and collaborative support. Having invested more than 300,000 hours designing and implementing software solutions for laboratories, the Semaphore/Labbit team is committed to empowering organizations to enhance their operations, drive efficiency, and achieve scientific excellence by removing the friction that software so often applies to labs.    Categories: [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [Computing & Technology](https://news.lifesciencenewswire.com/newsroom/tag/computing-it), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) ##### Browse more news ## Recent releases #### [Enhanced Compliance Inc. (ECI) Appoints Taranjit S. Samra as Head of Medical Device Software Enginee...](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) July 6, 2026 Strengthens ECI’s AI & Digital Transformation capabilities to help clients develop the next generation of software-enabled medical technologies En... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) #### [Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomic...](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) June 16, 2026 New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Gen... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) #### [Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) June 16, 2026 Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company’s Next Phase of Growth in Customized Interleukin Therapies ARScience... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)